Literature DB >> 27339680

Infections in Liver Disease.

Rahul S Nanchal1, Shahryar Ahmad2.   

Abstract

Infectious complications are common occurrences in end-stage liver disease (ESLD). Frequent infections precipitate decompensation of liver disease leading to acute or chronic liver failure, organ dysfunction, de-listing from transplant, and major morbidity and mortality. The spectrum of microorganisms has shifted with the emergence of multidrug-resistant strains, which has major implications for both therapy and prophylaxis. Cirrhosis is often associated with an underlying noninfectious systemic inflammatory state that makes diagnosis of infections particularly challenging. Adequate resuscitation and timely administration of appropriate antibiotics are pivotal to improved outcomes from infections in ESLD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Acute on chronic liver failure; Antibiotics; Cirrhosis; Cirrhosis-associated immune dysfunction; Infections; Sepsis; Septic shock

Mesh:

Substances:

Year:  2016        PMID: 27339680     DOI: 10.1016/j.ccc.2016.03.006

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  8 in total

1.  Hepatobiliary Quiz Answers-19 (2016).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2016-10-03

2.  Prognostic factors of the short-term outcomes of patients with hepatitis B virus-associated acute-on-chronic liver failure.

Authors:  Qing Lei; Kangjian Ao; Yinhua Zhang; Deqiang Ma; Deping Ding; Changzheng Ke; Yue Chen; Jie Luo; Zhongji Meng
Journal:  Clinics (Sao Paulo)       Date:  2017-11       Impact factor: 2.365

3.  Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016.

Authors:  Tingting Xiao; Kai Yang; Yanzi Zhou; Shuntian Zhang; Jinru Ji; Chaoqun Ying; Ping Shen; Yonghong Xiao
Journal:  Antimicrob Resist Infect Control       Date:  2019-08-27       Impact factor: 4.887

Review 4.  Acute-on-chronic liver failure: Objective admission and support criteria in the intensive care unit.

Authors:  Victor Dong; Constantine J Karvellas
Journal:  JHEP Rep       Date:  2019-03-18

5.  Characterisation of blood microbiota in patients with liver cirrhosis.

Authors:  Mikio Kajihara; Shigeo Koido; Tomoya Kanai; Zensho Ito; Yoshihiro Matsumoto; Kazuki Takakura; Masayuki Saruta; Kumiko Kato; Toshitaka Odamaki; Jin-Zhong Xiao; Nobuhiro Sato; Toshifumi Ohkusa
Journal:  Eur J Gastroenterol Hepatol       Date:  2019-12       Impact factor: 2.566

6.  Fungal urinary tract infection among chronic liver disease patients with hepatic encephalopathy and its treatment outcomes.

Authors:  Lubna Kamani; Hamid Kalwar
Journal:  JGH Open       Date:  2020-12-08

7.  Application of mNGS in the Etiological Diagnosis of Thoracic and Abdominal Infection in Patients With End-Stage Liver Disease.

Authors:  Hongmei Chen; Ye Zhang; Jie Zheng; Lei Shi; Yingli He; Yinghua Niu; Jine Lei; Yingren Zhao; Han Xia; Tianyan Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

8.  Application of metagenomic next-generation sequencing in cutaneous tuberculosis.

Authors:  Min Kong; Wei Li; Qingsheng Kong; Haixin Dong; Aizhong Han; Liqing Jiang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-23       Impact factor: 6.073

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.